Calendar Cabaletta Bio, Inc.

Equities

CABA

US12674W1099

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 19:04:36 23/06/2025 BST			5-day change	1st Jan Change
1.765 ^USD	-1.40%		-8.79%	-22.25%

06-11	Sector Update: Health Care Stocks Mixed Late Afternoon	MT
06-11	Top Midday Decliners	MT

Chart calendar Cabaletta Bio, Inc.

f4338967393fb8.7UAcxYbrxqvEKLuQ0UfRxo6S_QTisdJBvec6c1NODGU.3SctkrSzquf3Uo2jmH6givv7zUiSgoBxx60ISzEmRAjfGiyH85jy5Zxvgw~a695f054260fbe893d7b5f8e93f43f25

Upcoming events on Cabaletta Bio, Inc.

06/08/2025	Q2 2025 Earnings Release (Projected)
11/11/2025	Q3 2025 Earnings Release (Projected)
11/03/2026	Q4 2025 Earnings Release (Projected)

Past events on Cabaletta Bio, Inc.

10/06/2025	European Alliance of Associations for Rheumatology Congress
09/06/2025 14:00	Annual General Meeting
04/06/2025 16:05	Jefferies Healthcare Conference
31/03/2025 12:00	Q4 2024 Earnings Release
03/03/2025 16:50	TD Cowen Healthcare Conference
22/02/2025 09:15	International Lymphocyte Engineering Conference
15/02/2025 15:00	American Association for the Advancement of Science Meeting
05/02/2025 15:30	Guggenheim Securities SMID Cap Biotech Conference
04/12/2024 12:55	Evercore ISI HealthCONx Conference
03/12/2024	Citi Global Healthcare Conference
20/11/2024 11:30	Jefferies London Healthcare Conference
18/11/2024 13:00	American College of Rheumatology Meeting
17/11/2024 20:30	American College of Rheumatology Meeting - Abstract No 1857177
16/11/2024 15:30	American College of Rheumatology Meeting - Abstract No 1866605
14/11/2024 12:00	Q3 2024 Earnings Release
11/11/2024 15:00	Guggenheim Securities Healthcare Innovation Conference - Fireside Chat
17/09/2024 16:30	Cantor Global Healthcare Conference
11/09/2024 14:00	H.C. Wainwright Global Investment Conference
05/09/2024 13:00	Wells Fargo Healthcare Conference
04/09/2024 21:50	Morgan Stanley Healthcare Conference

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	5,83	3,33	4,28
EBITDA Million USD	Released Forecast Spread	-53,2 -52,4 -1.41%	-73,2 -68,5 -6.92%	-123 -125 1.64%	-162	-188	-217
EBIT Million USD	Released Forecast Spread	-54,1 -51,8 -4.53%	-74,7 -70,4 -6.09%	-125 -126 0.43%	-151	-173	-197
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-53,0 -51,1 -3.65%	-67,7 -64,2 -5.35%	-116 -116 -0.21%	-142	-164	-188
Net income Million USD	Released Forecast Spread	-53,0 -51,1 -3.65%	-67,7 -64,2 -5.37%	-116 -116 -0.21%	-144	-164	-188
EPS USD	Released Forecast Spread	-1,81 -1,72 -5.44%	-1,65 -1,59 -3.99%	-2,34 -2,23 -5.09%	-2,39	-2,16	-1,99
Announcement Date		16/03/23	21/03/24	31/03/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4
Net sales Million USD	Released Forecast Spread	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	0,00 0,00 -	4,17	0,83	0,83	1,67	1,67	1,67	1,67
EBITDA Million USD	Released Forecast Spread		-22,8 -18,9 -20.56%	-27,6 -23,3 -18.7%	-30,4 -28,4 -6.93%	-32,9 -32,1 -2.56%	-33,3 -35,1 5.04%	-36,7 -37,5 2.39%	-39,8	-43,4	-47,3
EBIT Million USD	Released Forecast Spread	-18,7 -17,7 -5.33%	-23,1 -19,2 -20.84%	-28,0 -23,0 -22.09%	-30,3 -29,3 -3.33%	-33,0 -32,3 -2.38%	-33,8 -34,6 2.23%	-37,1 -35,9 -3.33%	-38,1	-40,0	-41,6	-41,4	-42,3	-43,6	-43,9
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-16,4 -17,0 3.12%	-20,9 -17,6 -18.72%	-25,0 -21,4 -17.31%	-27,6 -27,5 -0.52%	-30,6 -30,2 -1.34%	-32,6 -32,5 -0.18%	-35,9 -33,1 -8.59%	-36,2	-37,8	-38,2	-40,4	-41,3	-42,6	-42,9
Net income Million USD	Released Forecast Spread	-16,4 -17,0 3.12%	-20,9 -17,6 -18.72%	-25,0 -21,4 -17.31%	-27,6 -27,5 -0.52%	-30,6 -30,2 -1.34%	-32,6 -32,5 -0.18%	-35,9 -33,1 -8.51%	-36,2	-37,8	-38,2	-40,4	-41,3	-42,6	-42,9
EPS USD	Released Forecast Spread	-0,37 -0,41 9.12%	-0,46 -0,39 -17.61%	-0,51 -0,48 -7.24%	-0,56 -0,55 -2.22%	-0,62 -0,59 -4.3%	-0,65 -0,63 -3.79%	-0,71 -0,66 -8.26%	-0,64	-0,65	-0,58	-0,48	-0,49	-0,46	-0,50
Announcement Date		09/11/23	21/03/24	15/05/24	08/08/24	14/11/24	31/03/25	15/05/25	-	-	-	-	-	-	-

Upcoming sector events for Cabaletta Bio, Inc.

02/07/2025	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release (Projected)
09/07/2025	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
22/07/2025	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
23/07/2025	BIOCON LIMITED: Q1 2026 Earnings Release (Projected)
29/07/2025	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Cabaletta Bio, Inc.

12/06/2025	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 07:46	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 09:21	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
15/05/2025 13:00	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release
14/05/2025	LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release
14/05/2025	PEPTRON, INC.: Q1 2025 Earnings Release
14/05/2025	OLIX PHARMACEUTICALS, INC: Q1 2025 Earnings Release
14/05/2025 21:05	ENLIVEN THERAPEUTICS, INC.: Q1 2025 Earnings Release
14/05/2025 12:00	SCHOLAR ROCK HOLDING CORPORATION: Q1 2025 Earnings Release
14/05/2025 02:00	BELITE BIO, INC: Q1 2025 Earnings Release